Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Non-Randomized, Open Label Study Of Azithromycin Intravenous Followed By Oral Administration In Japanese Adult Subjects With Pelvic Inflammatory Disease (PID) Requiring Initial Intravenous Therapy

NCT00871494 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00871494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00871494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Non-Randomized, Open Label Study Of Azithromycin Intravenous Followed By Oral Administration In Japanese Adult Subjects With Pelvic Inflammatory Disease (PID) Requiring Initial Intravenous Therapy
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2009
Completion date
November 30, 2010
Enrollment
76 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic inflammatory disease